Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells

Regulation of the mevalonate pathway

1990 • 5,282 citations

Small GTP-Binding Proteins

2001 • 2,449 citations

Head and Neck Cancer

1993 • 2,263 citations

Features of apoptotic cells measured by flow cytometry

1992 • 1,912 citations

Apoptosis in cancer therapy: Crossing the threshold

1994 • 1,351 citations

Cancer statistics, 1994

1994 • 1,345 citations

The EGF receptor family as targets for cancer therapy

2000 • 1,339 citations

Oxaliplatin: A review of preclinical and clinical studies

1998 • 611 citations

Cisplatin: From DNA damage to cancer chemotherapy

2001 • 595 citations

Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death

1999 • 579 citations

Cancer statistics, 1992

1992 • 540 citations

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1994 • 523 citations

Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

1991 • 468 citations

Rab GTPases, intracellular traffic and disease

2002 • 463 citations

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

2001 • 463 citations

5-Fluorouracil: Forty-Plus and Still Ticking. A Review of its Preclinical and Clinical Development

2000 • 388 citations

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

1996 • 368 citations

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

2001 • 354 citations

Ras and Rho regulation of the cell cycle and oncogenesis

2001 • 316 citations

Pharmacology of competitive inhibitors of HMg-CoA reductase

1995 • 276 citations

Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.

1999 • 255 citations

Increased Sensitivity of Acute Myeloid Leukemias to Lovastatin-Induced Apoptosis: A Potential Therapeutic Approach

1999 • 206 citations

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck

1998 • 203 citations

HMG CoA reductase inhibitors

1992 • 195 citations

Tyrosine kinase inhibitors—ZD1839 (Iressa)

2001 • 171 citations

The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.

1997 • 168 citations

Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.

2001 • 164 citations

CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.

1977 • 150 citations

Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.

2000 • 133 citations

Cisplatin

1999 • 120 citations

HMG–CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P–glycoprotein–expressing cells

1996 • 106 citations

EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells

2001 • 105 citations

Microarray and Biochemical Analysis of Lovastatin-induced Apoptosis of Squamous Cell Carcinomas

2002 • 98 citations

Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis‐dependent mechanism

2002 • 85 citations

Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells

1993 • 82 citations

Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.

1998 • 68 citations

Chemotherapy in the management of squamous-cell carcinoma of the head and neck

2001 • 64 citations

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

2002 • 58 citations

Chemotherapy for Recurrent and Metastatic Head and Neck Cancer

1991 • 56 citations

Role of conformational alteration in the epidermal growth factor receptor (EGFR) function

2000 • 55 citations

Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro

1999 • 48 citations

Discrimination techniques applied to the NCI in vitro anti‐tumour drug screen: Predicting biochemical mechanism of action

1994 • 38 citations

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer

1998 • 36 citations

Phosphorylation of Tyrosine 992, 1068, and 1086 Is Required for Conformational Change of the Human Epidermal Growth Factor Receptor C-Terminal Tail

1999 • 33 citations

Apoptosis modulators as cancer therapeutics.

2001 • 26 citations

New Platinum Agents

1994 • 19 citations

The Evaluation and Treatment of the Neck in Carcinoma of the Oral Cavity

1997 • 9 citations

Biosynthesis of the epidermal growth factor receptor: Post-translational glycosylation-independent acquisition of tyrosine kinase autophosphorylation activity

1988 • 8 citations

The induction of P450-mediated oxidation of all-trans retinoic acid by retinoids in head and neck squamous cell carcinoma cell lines

1998 • 8 citations